This product is a recombinant chimeric (human/mouse) Fab that recognizes the first HLA-DR domains. Chimeric DN1924 is effective in inducing apoptosis in HLA-DR-expressing tumor cells, but not in HLA-DR-negative tumor cells or in normal HLA-DR-expressing cells. It has the potential to reduce the rate of tumor growth and promote increased survival.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2072z | Mouse Anti-HLA-DRA Recombinant Antibody (clone 16F11) | WB, ELISA, FC, ICC, IHC | Mouse IgG2b |
VS3-WK1317 | Mouse Anti-HLA-DRA Recombinant Antibody (VS3-WK1317) | ELISA, WB | Mouse IgG1 |
VS-0724-XY76 | Human Anti-HLA-DRA Recombinant Antibody (clone c44H10) | ELISA, BLI | Human IgG |
VS-0724-XY78 | Monkey Anti-HLA-DRA Recombinant Antibody (clone MS-GPC-8-10-57) | ELISA, BLI, Neut | Monkey IgG4 |
VS-0724-XY77 | Mouse Anti-HLA-DRA Recombinant Antibody (clone K8-355) | ELISA, FC | Mouse IgG1 kappa |
There are currently no Customer reviews or questions for HPAB-0025-YJ-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.